About Index Trending news
Analyze
Pricing
Mylan

Mylan

Mylan

Official page for Mylan, where we work around the clock and around the globe to help provide 7 billion people access to high quality medicine

Elsewhere

Alexa global traffic share

Twitter followers

Employees

Team size

10000+
Ars Technica

Mylan board survives shareholder vote, but gets pushback on its compensation

Strategy
Ars Technica

With help of coal tax credits, Mylan had a negative 294-percent tax rate in 2016

Stock markets Strategy
Ars Technica

Mylan chairman: Drug pricing critics ought to go copulate with themselves

Costs Communities Health
Quartz

How Mylan got away with overcharging Medicaid $1.3 billion for EpiPen

Ars Technica

Mylan shareholders revolt, say directors’ greed has gone too far

Stock markets
Ars Technica

Mylan bullied, sued states to get them to use EpiPens, court documents show

Ars Technica

FDA lashes out at Mylan for dismal quality control at HIV drug facility

Ars Technica

Despite what Mylan said, its price hikes hit patients’ wallets hard

Health Costs Earnings
The Verge

EpiPen maker Mylan is under investigation by the Federal Trade Commission

US elections
Ars Technica

For ripping off Medicaid, EpiPen maker Mylan pays Feds $465 million

Health Costs Privacy
Slashdot

Feds Go After Mylan For Scamming Medicaid Out of Millions On EpiPen Pricing

@drkiki via Ars Technica

Mylan CEO misled lawmakers about EpiPen profits—they’re 66% higher

Earnings
Ars Technica

EpiPen maker Mylan may have used illegal deals with schools to price gouge

Costs Legal
Business Insider

Elizabeth Warren just demanded Mylan come clean about one of the biggest secrets in pharma

Costs Health
Ars Technica

EpiPen maker Mylan reveals generic—it’s only triple the price

Costs Earnings
Xconomy

Bio Roundup: Mylan's Shock, Hillary's 3%, Duchenne Lessons & More

Ars Technica

Mylan CEO “frustrated” by own price gouging but doesn’t lower EpiPen price

Costs Health
The Verge

EpiPen maker Mylan will make its allergy treatment more affordable

Costs Health
The Motley Fool

Mylan N.V. Reports Solid Q1 Revenue Growth, With Europe Leading the Way

The Motley Fool

Why Earnings Sent Mylan N.V. Shares Tumbling 18% Today